(Q33633286)

English

BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Leishmania major

object named as

Leishmania major

1 reference

based on heuristic

inferred from title

Manoel Barral-Netto

6

object named as

Manoel Barral-Netto

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

object named as

Laura Ramírez

1

0 references

Salvador Iborra

object named as

Salvador Iborra

2

0 references

7

object named as

Manuel Soto

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Jimena Cortés

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Pedro Bonay

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Carlos Alonso

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

26 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Journal of Biomedicine and Biotechnology

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

181690

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Vaccines for leishmaniasis in the fore coming 25 years.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Second-generation vaccines against leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Recombinant DNA-derived leishmania proteins: from the laboratory to the field

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Recent advances in vaccines for leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

The immunology of susceptibility and resistance to Leishmania major in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Type 1 and type 2 responses to Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Molecular aspects of parasite-vector and vector-host interactions in leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Leishmaniasis: current status of vaccine development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Interleukin-10 and the interleukin-10 receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Susceptibility to Leishmania major infection in the absence of IL-4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Mechanisms of helper T-cell regulation of B-cell activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

The regulation of immunity to Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

The present and future of vaccination for cutaneous leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

Role of T cell subsets during the recall of immunologic memory to Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

21 June 2018

2 references

https://api.crossref.org/works/10.1155%2F2010%2F181690

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/20145701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge.

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F181690

21 January 2018

Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F181690

21 January 2018

DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F181690

21 January 2018

The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F181690

21 January 2018

Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2817367

30 October 2018

Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F181690

21 January 2018

Searching Genes Encoding Leishmania Antigens for Diagnosis and Protection

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F181690

21 January 2018

The role of IL-10 in promoting disease progression in leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20145701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Relative Contribution of IL-4 Receptor Signaling and IL-10 to Susceptibility toLeishmania major

1 reference

https://pubmed.ncbi.nlm.nih.gov/20145701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20145701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive transfer of dendritic cells pulsed with Leishmania infantum nucleosomal histones confers protection against cutaneous leishmaniosis in BALB/c mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20145701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transitory or long-lasting immunity to Leishmania major infection: the result of immunogenicity and multicomponent properties of histone DNA vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/20145701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20145701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2010/181690

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33633286&oldid=1801867738"